过去一年中添加的文章，按日期排序
[HTML][HTML] Risk Factors for Infection After Transrectal Prostate Biopsy: A Population-based Register Study
J Örtegren, K Kohestani, O Elvstam, H Janson… - European Urology Open …, 2024 - Elsevier
10 天前 - … for safe TPBx as an alternative to a change in biopsy route. The aim of this study was
to … , diabetes mellitus, prostate cancer diagnosed at index biopsy, previous prostate biopsy, …
to … , diabetes mellitus, prostate cancer diagnosed at index biopsy, previous prostate biopsy, …
[HTML][HTML] Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer
SH Tolmeijer, E Boerrigter, NP Van Erp, N Mehra - Oncotarget, 2024 - ncbi.nlm.nih.gov
20 天前 - … for mCRPC was treatment with an androgen receptor pathway inhibitor (ARPI), being
either … with persistent ctDNA detection (28 vs. 16 months). Thus, early changes in ctDNA …
either … with persistent ctDNA detection (28 vs. 16 months). Thus, early changes in ctDNA …
Combination strategies to overcome radioresistance in metastatic Castration-Resistant Prostate Cancer
MB Idrissou, A Carston, A Thickens, H Hansel Rojas… - 2024 - Soc Nuclear Med
51 天前 - … blood count (CBC), comprehensive metabolic panel (CMP), and body weight change.
… From both DDR pathway inhibitions, BETi emerged as the most potent sensitizer strategy …
… From both DDR pathway inhibitions, BETi emerged as the most potent sensitizer strategy …
A phase 2 trial of ADT interruption in patients responding exceptionally to AR-pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM/Alliance …
AD Choudhury, G Heller, MA Reimers, AL Laccetti… - 2024 - ascopubs.org
54 天前 - … every 6 months. Treatment re-initiation triggers are PSA increase to ≥ 5 ng/ml,
radiographic change … on bone scan), or symptoms attributable to prostate cancer. Subsequent …
radiographic change … on bone scan), or symptoms attributable to prostate cancer. Subsequent …
Comparison of outcomes with docetaxel or ARPI combination therapy for metastatic hormone-sensitive prostate cancer (mHSPC) by volume of disease.
MW Schoen, RD Etzioni, S Luo, D Candelieri, N Fedele… - 2024 - ascopubs.org
54 天前 - … (DOC) or the androgen receptor pathway inhibitors (ARPIs) … identified with initial
diagnosis of ‘distant’ prostate cancer. … specific antigen, body mass index, and weight change in …
diagnosis of ‘distant’ prostate cancer. … specific antigen, body mass index, and weight change in …
Baseline ctDNA analyses and associations with outcomes in taxane-naive patients with mCRPC treated with 177Lu-PSMA-617 versus change of ARPI in PSMAfore.
54 天前 - … pathway inhibitor (ARPI) change in taxane-naive patients with metastatic
castration-resistant prostate cancer … Detection of ctDNA alterations was comparable between arms …
castration-resistant prostate cancer … Detection of ctDNA alterations was comparable between arms …
COBRA: Assessment of safety and efficacy of 64Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy.
L Nordquist, E Lengyelova, D Saltzstein, D Josephson… - 2024 - ascopubs.org
54 天前 - … Standard (histopathology, SOC imaging, Prostate Specific Antigen response) that
was … included detection rate (DR) and positive predictive value (PPV). The intended change in …
was … included detection rate (DR) and positive predictive value (PPV). The intended change in …
A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer's Disease Risk in Older Men with Prostate Cancer
66 天前 - … diagnostic and therapeutic avenues for alleviating PCa and ADT-related cognitive
sequelae by unravelling these complicated pathways … In conclusion, the changing landscape …
sequelae by unravelling these complicated pathways … In conclusion, the changing landscape …
[引用][C] Changes in cardiorespiratory fitness, body composition, inflammation, and the gut microbiome in cancer survivors in response to high intensity interval training
A Boytar - 2024 - espace.library.uq.edu.au
68 天前 - … have been diagnosed and treated for cancer. However, … pathways for exercise-mediated
changes in humans will enhance our understanding of the role of exercise in cancer …
changes in humans will enhance our understanding of the role of exercise in cancer …
Dynamic changes in proteome activity landscapes in treatment-resistant-prostate cancer
SS Sundar, S Gulla, E Gardner, L McClinton… - 2024 - ASPET
77 天前 - … /MS analysis to detect protein abundance. Integrative pathway analysis was performed
… Reactome and GO pathway analysis indicated a robust change in the proteome activity …
… Reactome and GO pathway analysis indicated a robust change in the proteome activity …